Obesity Clinical Trial
Official title:
Exploring the Short-Term Effect of Bariatric Surgery on Muscle Structure And Function; Followed By A Feasibility Assessment Of Exercise Intervention Post Bariatric Surgery
NCT number | NCT05569785 |
Other study ID # | 22012 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | March 1, 2023 |
Est. completion date | December 1, 2024 |
The purpose of this project is to assess the effects of bariatric surgery on muscle structure and function as well as investigating the feasibility of undertaking an exercise intervention post-surgery.
Status | Recruiting |
Enrollment | 12 |
Est. completion date | December 1, 2024 |
Est. primary completion date | June 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: - Obese adults (BMI greater than or equal to 35 kg/m2) - Age range 18-70 years old - Scheduled for RYGB surgery or sleeve gastrectomy surgery. - Ability to give informed consent Exclusion Criteria: - Patients who are not fit or not suitable for RYGB or Sleeve Gastrectomy as per Tier 4 Bariatric Surgery MDT. - For those high-risk patients who are fast tracked to surgery, we will exclude patients with a NYHA >3 or 4 heart failure status and those with end stage renal failure. - BMI greater than or equal to 60 |
Country | Name | City | State |
---|---|---|---|
United Kingdom | COMAP | Derby |
Lead Sponsor | Collaborator |
---|---|
University of Nottingham |
United Kingdom,
Alba DL, Wu L, Cawthon PM, Mulligan K, Lang T, Patel S, King NJ, Carter JT, Rogers SJ, Posselt AM, Stewart L, Shoback DM, Schafer AL. Changes in Lean Mass, Absolute and Relative Muscle Strength, and Physical Performance After Gastric Bypass Surgery. J Clin Endocrinol Metab. 2019 Mar 1;104(3):711-720. doi: 10.1210/jc.2018-00952. — View Citation
Haeffener MP, Ferreira GM, Barreto SS, Arena R, Dall'Ago P. Incentive spirometry with expiratory positive airway pressure reduces pulmonary complications, improves pulmonary function and 6-minute walk distance in patients undergoing coronary artery bypass graft surgery. Am Heart J. 2008 Nov;156(5):900.e1-900.e8. doi: 10.1016/j.ahj.2008.08.006. Epub 2008 Oct 5. — View Citation
Herring LY, Stevinson C, Carter P, Biddle SJH, Bowrey D, Sutton C, Davies MJ. The effects of supervised exercise training 12-24 months after bariatric surgery on physical function and body composition: a randomised controlled trial. Int J Obes (Lond). 2017 Jun;41(6):909-916. doi: 10.1038/ijo.2017.60. Epub 2017 Mar 6. — View Citation
Li C, Carli F, Lee L, Charlebois P, Stein B, Liberman AS, Kaneva P, Augustin B, Wongyingsinn M, Gamsa A, Kim DJ, Vassiliou MC, Feldman LS. Impact of a trimodal prehabilitation program on functional recovery after colorectal cancer surgery: a pilot study. Surg Endosc. 2013 Apr;27(4):1072-82. doi: 10.1007/s00464-012-2560-5. Epub 2012 Oct 9. — View Citation
Santa Mina D, Clarke H, Ritvo P, Leung YW, Matthew AG, Katz J, Trachtenberg J, Alibhai SM. Effect of total-body prehabilitation on postoperative outcomes: a systematic review and meta-analysis. Physiotherapy. 2014 Sep;100(3):196-207. doi: 10.1016/j.physio.2013.08.008. Epub 2013 Nov 13. — View Citation
Wadstrom C, Backman L, Forsberg AM, Nilsson E, Hultman E, Reizenstein P, Ekman M. Body composition and muscle constituents during weight loss: studies in obese patients following gastroplasty. Obes Surg. 2000 Jun;10(3):203-13. doi: 10.1381/096089200321643313. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To assess the effects of bariatric surgery on skeletal muscle ultrasound thickness. | This will be assessed using muscle ultrasound and units (mm) | Total duration of study per participant is expected to be 13 to 14 weeks | |
Primary | To assess the effects of bariatric surgery on skeletal muscle cross sectional area (cm2) | This will be assessed using muscle ultrasound | Total duration of study per participant is expected to be 13 to 14 weeks | |
Primary | Assessment of percentage of patients who were retained throughout the intervention arm of the study | To be measured as percentage. | Total duration of study per participant is expected to be 13 to 14 weeks | |
Primary | Assessment of percentage of patients who were compliant with the intervention arm of the study. To be guided by FitBit monitor use. | This assessment will be measured as percentage of patients who met compliance targets with the intervention arm for the study. | Total duration of study per participant is expected to be 13 to 14 weeks | |
Primary | Assessment of number of patients who were recruited to the study | This assessment will be measured as a simple numeric value | Total duration of study per participant is expected to be 13 to 14 weeks | |
Secondary | Fasting glucose | These results will be undertaken by analysing blood samples taken by venepuncture of participants. Units will be mmol . | Total duration of study per participant is expected to be 13 to 14 weeks, there will be bloods taken on each in-person study day. Plan is for 3 of these days, screening bloods will be reviewed from the NHS interface. | |
Secondary | Skeletal muscle architecture (fibre length) | An ultrasound scan will be used for the purpose of this measurement. Units (mm). | Total duration of study per participant is expected to be 13 to 14 weeks, ultrasounds will be performed at each in-person study day. performed on each in-person study day | |
Secondary | Muscle fatigability (maximum voluntary contractions) | This is the maximal force-generating capacity of a muscle or group of muscles | Total duration of study per participant is expected to be 13 to 14 weeks, each assessment for this outcome will take place at the in-person study days. | |
Secondary | Lean body mass using BIA and D3 creatine | These are stable biomarkers that have been previously used in research. It acts in the body as creatine, which is a naturally occurring substance. | Total duration of study per participant is expected to be 13 to 14 weeks, each participant will be provided with the resources to facilitate these assessments at their in-person study days, urine collections will be returned later.. | |
Secondary | Motor control in force tracking | As part of the Short Physical Performance Battery Test | Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day. | |
Secondary | Balance using the Timed Up and Go (TUG) test | As part of the Short Physical Performance Battery Test | Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day. | |
Secondary | Balance in Gait and Motion testing | As part of the Short Physical Performance Battery Test | Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day. | |
Secondary | Hand grip strength | The purpose of the handgrip strength test is to measure the maximum isometric strength of the hand and forearm muscles | Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day. | |
Secondary | Predicted maximum oxygen consumption (VO2 max) in step box test | As part of the Short Physical Performance Battery Test | Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day. | |
Secondary | Skin fold and body circumference measurements | To assess for any interval change | Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day. | |
Secondary | Quality of life measurements using IPAQ questionnaire | Questionnaires are performed to standardise the assessment of quality of life from the patient perspective. IPAQ questionnaire contains open-ended questions surrounding individuals' last 7-day recall of physical activity | Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day. | |
Secondary | insulin resistance (HOMA-IR) | These results will be undertaken by analysing blood samples taken by venepuncture of participants. Units will be nmol/L. | Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day. | |
Secondary | Skeletal muscle architecture (pennation angle) | An ultrasound scan will be used for the purpose of this measurement, units will be in degrees. | Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day. | |
Secondary | Quality of life measurements using SF-36 questionnaire | Questionnaires are performed to standardise the assessment of quality of life from the patient perspective.This questionnaire uses a likert scale as means of assessment. | Total duration of study per participant is expected to be 13 to 14 weeks, these assessments will be performed at each in-person study day. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |